Product NDC: | 0093-9200 |
Proprietary Name: | Lidocaine Hydrochloride |
Non Proprietary Name: | Lidocaine Hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; Lidocaine Hydrochloride |
Administration Route(s): | TOPICAL |
Dosage Form(s): | JELLY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-9200 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA081318 |
Marketing Category: | ANDA |
Start Marketing Date: | 19950101 |
Package NDC: | 0093-9200-31 |
Package Description: | 30 mL in 1 TUBE, WITH APPLICATOR (0093-9200-31) |
NDC Code | 0093-9200-31 |
Proprietary Name | Lidocaine Hydrochloride |
Package Description | 30 mL in 1 TUBE, WITH APPLICATOR (0093-9200-31) |
Product NDC | 0093-9200 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lidocaine Hydrochloride |
Dosage Form Name | JELLY |
Route Name | TOPICAL |
Start Marketing Date | 19950101 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | LIDOCAINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE] |